MC2 Therapeutics announces that Chief Executive Officer Jesper J. Lange will give a business update at Carnegie’s Next General Nordic Life Science Champions Seminar 2022 for non-listed companies. MC2 Therapeutics is a privately held commercial stage pharmaceutical company, engaged in research in skin biology and development of novel treatment paradigms for autoimmune and chronic inflammatory skin conditions
The presentation will take place live via webcast on Wednesday December 7th at 14:05pm CET and can be accessed here – Password: NordicNextGen2022.
BACK
